NSG 6005
FINAL PHARMACOLOGY
EXAM
Actual Qs & Ans to Pass the Exam
THIS EXAM CONSIST OF
➢ Questions covering NSG 6005 Midterm week 5
➢ multiple-choice format (A, B, C, D) with Correct Answers
➢ Some questions feature brief "scenario" elements and rationales
➢ 100 Questions with 100% Correct Answers
,1. Disease states in addition to hypertension in which beta blockade is a compelling indication
for the use of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
Correct Answer: C. MI
Expert Rationale:
Beta-blockers reduce myocardial oxygen demand, decrease cardiac workload, and improve
survival post–myocardial infarction. They are first-line therapy after MI. While they may be used
in HF and angina, the most compelling evidence-based indication is secondary prevention post-
MI.
2. When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved
C. Blood glucose must be monitored every three to four months
D. There is no laboratory monitoring required
Correct Answer: D. There is no laboratory monitoring required
Expert Rationale:
SSRIs do not require routine serum drug levels or lab monitoring, unlike lithium or tricyclics.
Clinical monitoring for side effects, serotonin syndrome, and suicidal ideation is essential.
3. Chemical dependency assessment is integral to the initial assessment of chronic pain.
Which of the following raises a "red flag" about potential chemical dependency?
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
Correct Answer: B. Multiple times when prescriptions are lost with requests to refill
,Expert Rationale:
Repeatedly “losing” prescriptions or requesting early refills is a classic indicator of possible
opioid misuse or diversion. While family history is a risk factor, behavior patterns like refill
irregularities raise stronger suspicion.
4. Prescribing for women during their childbearing years requires constant awareness of the
possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
Correct Answer: B. Risk for silent bacterial or viral infections of the genitalia
Expert Rationale:
Silent STIs (e.g., chlamydia, HPV, HSV) are common in women of childbearing age and may
significantly impact fertility and pregnancy outcomes. Prescribers must consider both
teratogenic risk and infection risk when prescribing.
5. First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
Correct Answer: C. Lifestyle changes
Expert Rationale:
Guidelines stress diet, exercise, and weight management as the foundation for hyperlipidemia
treatment. Statins are added if therapeutic lifestyle changes fail to achieve lipid targets or if
ASCVD risk is high.
6. The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
, D. Provides prescribers with a number they can use for insurance billing
Correct Answer: A. Registers manufacturers and prescribes controlled substances
Expert Rationale:
The DEA (Drug Enforcement Administration) oversees controlled substances manufacturing,
distribution, and prescriber registration. NP prescribing rules are regulated at the state level,
not federally by DEA.
7. Cecilia presents with depression associated with complaints of fatigue, sleeping all the
time, and lack of motivation. An appropriate initial antidepressant for her would be:
A. Fluoxetine (Prozac)
B. Paroxetine (Paxil)
C. Amitriptyline (Elavil)
D. Duloxetine (Cymbalta)
Correct Answer: D. Duloxetine (Cymbalta)
Expert Rationale:
Duloxetine is an SNRI with benefit for fatigue, low energy, and somatic symptoms of depression.
SSRIs like fluoxetine may worsen insomnia, and TCAs like amitriptyline have more adverse
effects.
8. Sarah, a forty-two-year-old female, requests a prescription for an anorexiant to treat her
obesity. A trial of phentermine is prescribed. Prescribing precautions include understanding
that:
A. Obesity is a contraindication to prescribing phentermine.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
C. Patients should be monitored for postural hypotension.
D. Renal function should be monitored closely while the patient is on anorexiants.
Correct Answer: B. Anorexiants may cause tolerance and should only be prescribed for six
months
Expert Rationale:
Phentermine and other sympathomimetic anorexiants are FDA-approved only for short-term
therapy (≤12 weeks). Long-term use carries risks of tolerance, dependence, and cardiovascular
adverse events.
FINAL PHARMACOLOGY
EXAM
Actual Qs & Ans to Pass the Exam
THIS EXAM CONSIST OF
➢ Questions covering NSG 6005 Midterm week 5
➢ multiple-choice format (A, B, C, D) with Correct Answers
➢ Some questions feature brief "scenario" elements and rationales
➢ 100 Questions with 100% Correct Answers
,1. Disease states in addition to hypertension in which beta blockade is a compelling indication
for the use of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
Correct Answer: C. MI
Expert Rationale:
Beta-blockers reduce myocardial oxygen demand, decrease cardiac workload, and improve
survival post–myocardial infarction. They are first-line therapy after MI. While they may be used
in HF and angina, the most compelling evidence-based indication is secondary prevention post-
MI.
2. When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved
C. Blood glucose must be monitored every three to four months
D. There is no laboratory monitoring required
Correct Answer: D. There is no laboratory monitoring required
Expert Rationale:
SSRIs do not require routine serum drug levels or lab monitoring, unlike lithium or tricyclics.
Clinical monitoring for side effects, serotonin syndrome, and suicidal ideation is essential.
3. Chemical dependency assessment is integral to the initial assessment of chronic pain.
Which of the following raises a "red flag" about potential chemical dependency?
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
Correct Answer: B. Multiple times when prescriptions are lost with requests to refill
,Expert Rationale:
Repeatedly “losing” prescriptions or requesting early refills is a classic indicator of possible
opioid misuse or diversion. While family history is a risk factor, behavior patterns like refill
irregularities raise stronger suspicion.
4. Prescribing for women during their childbearing years requires constant awareness of the
possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
Correct Answer: B. Risk for silent bacterial or viral infections of the genitalia
Expert Rationale:
Silent STIs (e.g., chlamydia, HPV, HSV) are common in women of childbearing age and may
significantly impact fertility and pregnancy outcomes. Prescribers must consider both
teratogenic risk and infection risk when prescribing.
5. First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
Correct Answer: C. Lifestyle changes
Expert Rationale:
Guidelines stress diet, exercise, and weight management as the foundation for hyperlipidemia
treatment. Statins are added if therapeutic lifestyle changes fail to achieve lipid targets or if
ASCVD risk is high.
6. The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
, D. Provides prescribers with a number they can use for insurance billing
Correct Answer: A. Registers manufacturers and prescribes controlled substances
Expert Rationale:
The DEA (Drug Enforcement Administration) oversees controlled substances manufacturing,
distribution, and prescriber registration. NP prescribing rules are regulated at the state level,
not federally by DEA.
7. Cecilia presents with depression associated with complaints of fatigue, sleeping all the
time, and lack of motivation. An appropriate initial antidepressant for her would be:
A. Fluoxetine (Prozac)
B. Paroxetine (Paxil)
C. Amitriptyline (Elavil)
D. Duloxetine (Cymbalta)
Correct Answer: D. Duloxetine (Cymbalta)
Expert Rationale:
Duloxetine is an SNRI with benefit for fatigue, low energy, and somatic symptoms of depression.
SSRIs like fluoxetine may worsen insomnia, and TCAs like amitriptyline have more adverse
effects.
8. Sarah, a forty-two-year-old female, requests a prescription for an anorexiant to treat her
obesity. A trial of phentermine is prescribed. Prescribing precautions include understanding
that:
A. Obesity is a contraindication to prescribing phentermine.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
C. Patients should be monitored for postural hypotension.
D. Renal function should be monitored closely while the patient is on anorexiants.
Correct Answer: B. Anorexiants may cause tolerance and should only be prescribed for six
months
Expert Rationale:
Phentermine and other sympathomimetic anorexiants are FDA-approved only for short-term
therapy (≤12 weeks). Long-term use carries risks of tolerance, dependence, and cardiovascular
adverse events.
